OpenAlex
PricingAboutJobs
Log inGet started
Work

The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy

HTML

Year: 2008
Type: review
Source: The Oncologist
DOI: 10.1634/theoncologist.2008-0089
Authors: Xuhui Zhou, Weiguo Hu, Xuebin Qin
Institutions: Second Military Medical University, Shanghai Changzheng Hospital, Brigham and Women's Hospital, Harvard University
Language: English

Topic: Lymphoma Diagnosis and Treatment
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Keywords: rituximab, complement system, B-cell non-Hodgkin lymphoma, complement-dependent cytotoxicity, antibody-dependent cellular cytotoxicity, CD20, rituximab resistance, CD59, cobra venom factor, C3b, CR3, β-glucan, apoptosis, monoclonal antibody therapy
SDG: Good health and well-being

Open Access status: closed

Funders: American Heart Association, National Institutes of Health, U.S. Food and Drug Administration, National Institute of Allergy and Infectious Diseases
Award: Towards a Mouse Model of Complement-Mediated Diseases
OpenAlex ID: W2162305597
FWCI: 2.532
Cites: 143
Cited by: 202
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms